Financials

  • Market Capitalization 3.62 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
41.95
ratio cours/chiffre d'affaires
8.46

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1543
DNLI
Denali Therapeutics Inc. - Common Stock
23.16 USD-0.47%-5.74%+1.36%+43.23%3.70 B USD
1555
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.58 USD+6.73%+3.58%+13.53%+83.52%3.92 B USD
1596
ABCL
AbCellera Biologics Inc. - Common Shares
11.33 USD+0.44%-6.90%+98.77%+179.06%3.47 B USD
1618
GPCR
Structure Therapeutics Inc - American Depositary Shares
47.45 USD+0.68%-2.53%-1.15%+77.45%3.38 B USD

Nouvelles